Pharmaceutical Science
A section of Life (ISSN 2075-1729).
Section Information
This section of the journal Life aims to rapidly publish contributions related to pharmaceutical science. We encourage the submission of manuscripts that report significant advances in those fields. Topics include, but are not limited to, the following:
- pharmaceutical technology, pharmaceutics, novel drug delivery, biopharmaceutics, pharmacokinetics
- basic and clinical pharmacology, toxicology
- medicinal chemistry, computational chemistry and molecular drug design, pharmaceutical and biomedicinal analysis
- pharmacogenetics, pharmacogenomics
- epigenetic drugs, pharmacoepigenetics
- biotechnological products
Editorial Board
Topical Advisory Panel
Special Issues
Following special issues within this section are currently open for submissions:
- Omics Approaches in Antipsychotic Pharmacology (Deadline: 28 August 2026)
- The Biochemistry of Venoms: Exploring Molecular Diversity, Structural Mechanisms, and Their Biotechnological Uses (Deadline: 31 August 2026)
- Bioactive Natural Products: From Exploration to Therapeutic Potential (Deadline: 16 September 2026)
- Advances in 5-Aminolevulinic Acid Applications in Medical and Healthcare (Deadline: 18 September 2026)
- Biochemical Modulators in Chronic Diseases: The Antioxidant/Anti-Inflammatory Interdependence—2nd Edition (Deadline: 30 September 2026)
- Drug Safety and Outcomes in Respiratory and Critical Care Medicine (Deadline: 30 November 2026)
- Novel Insights into Environmental Agents' Toxicity and Therapeutic Strategies (Deadline: 30 December 2026)
- Therapeutic Innovations from Plants and Their Bioactive Extracts (Deadline: 31 December 2026)
- Transformative Frontiers in Mental Health Treatment: Advances in Neuropsychopharmacology (Deadline: 27 January 2027)
- Innovations, Utilization, and Safety of Psychiatric Drugs: Current Trends and Future Directions (Deadline: 30 January 2027)
- Functional Plant-Based Extracts: Biosynthesis, Bioactivity, and Metabolic Disease Prevention (Deadline: 31 January 2027)
- Therapeutic Effects of Natural Products on Human Diseases—3rd Edition (Deadline: 25 February 2027)
- Drug Safety (Deadline: 31 March 2027)
- Nanocarriers for Inflammatory Skin Diseases and Beyond (Deadline: 30 April 2027)
- Pharmacology and Emerging Therapeutics for Lung Disorders (Deadline: 30 June 2027)
